Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

NCT03165188 is registered in ClinicalTrials.gov with NewLink Genetics Corporation as lead sponsor.

NCT NCT03165188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Lead sponsor
NewLink Genetics Corporation
Phase
Observational
Overall status
Terminated
Start date
September 1, 2017
Completion date
December 8, 2020
Enrollment
29 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer